Cargando…
Designer Cytokine Hyper Interleukin 11 (H11) is a Megakaryopoietic Factor
Interleukin-11 (IL-11) displays megakaryopoietic activity. We constructed super-cytokine Hyper- IL11 (H11) by linking soluble IL-11 receptor α (sIL-11Rα) with IL-11, which directly targets β-receptor (gp130) signal transducing subunit. The effects of H11 on hematopoiesis with a focus on megakaryopoi...
Autores principales: | Dams-Kozlowska, Hanna, Kwiatkowska-Borowczyk, Eliza, Gryska, Katarzyna, Mackiewicz, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714392/ https://www.ncbi.nlm.nih.gov/pubmed/23869192 http://dx.doi.org/10.7150/ijms.5638 |
Ejemplares similares
-
A designer hyper interleukin 11 (H11) is a biologically active cytokine
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2012) -
Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2016) -
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
por: Kwiatkowska-Borowczyk, Eliza, et al.
Publicado: (2018) -
Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a murine Tumor Rejection Model
por: Gąbka-Buszek, Agnieszka, et al.
Publicado: (2020) -
Cell-based Hyper-interleukin 6 or Hyper-interleukin 11 secreting vaccines combined with low dose cyclophosphamide in an orthotopic murine prostate cancer model
por: Mackiewicz, Jacek, et al.
Publicado: (2015)